Եվրոպական Միություն - խորվաթերեն - EMA (European Medicines Agency)

almirall s.a - dimetil fumarat - psorijaza - imunosupresivi - skilarencija je indicirana za liječenje umjerene do teške psorijaze plaka kod odraslih kojima je potrebna sustavna medicinska terapija.

Եվրոպական Միություն - խորվաթերեն - EMA (European Medicines Agency)

eli lilly nederland b.v. - abemaciclib - neoplazme dojki - antineoplastična sredstva - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Եվրոպական Միություն - խորվաթերեն - EMA (European Medicines Agency)

almirall s.a - tildrakizumab - psorijaza - imunosupresivima, inhibitori interleukina, - ilumetri indiciran za liječenje odraslih bolesnika s umjerenim do teškim plak psorijaza, koji su kandidati za sistemske terapije.

Եվրոպական Միություն - խորվաթերեն - EMA (European Medicines Agency)

eli lilly nederland b.v. - galcanezumab - migrena poremećaja - analgesics, galcanezumab - emgality je indiciran za prevenciju migrene kod odraslih koji imaju barem 4 dana migrene u mjesec.

Եվրոպական Միություն - խորվաթերեն - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - monohidrat Имипенем, циластатин natrija, relebactam monohidrat - Грамотрицательные bakterijske infekcije - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 i 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4 i 5. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje antibakterijskih posrednika.

Եվրոպական Միություն - խորվաթերեն - EMA (European Medicines Agency)

eli lilly nederland b.v. - glukagon - Šećerna bolest - hormoni pankreasa hormoni glycogenolytic - baqsimi naznačeno za liječenje teške hipoglikemije kod odraslih, djece i adolescenata u dobi od 4 i više godina s dijabetesom.

Եվրոպական Միություն - խորվաթերեն - EMA (European Medicines Agency)

eli lilly nederland b.v. - inzulin lispro - Šećerna bolest - lijekovi koji se koriste u dijabetesu - liječenje dijabetes melitusa kod odraslih, adolescenata i djece u dobi od 1 godine i više. liječenje dijabetes melitusa kod odraslih.

Եվրոպական Միություն - խորվաթերեն - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastična sredstva - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Եվրոպական Միություն - խորվաթերեն - EMA (European Medicines Agency)

albireo - odevixibat - cholestasis, intrahepatic - bile i jetrena terapija - bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (pfic) in patients aged 6 months or older (see sections 4. 4 i 5.

Եվրոպական Միություն - խորվաթերեն - EMA (European Medicines Agency)

almirall, s.a. - tirbanibulin - keratosis, actinić - antibiotici i kemoterapeutici za dermatološku uporabu - klisyri is indicated for the field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (olsen grade 1) of the face or scalp in adults.